Business Overview

BioScience
2010 Sales-$5.7 Billion

Baxter is a leading manufacturer of recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines.

Medical Products*
2010 Medication Delivery Sales-$4.8 Billion; 2010 Renal Sales-$2.4 Billion

Baxters Medical Products business manufactures products used in the delivery of fluids and drugs to patients. These include intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, IV nutrition products, infusion pumps and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, Baxter's Medical Products business is a leader in Renal home-based therapies, such as peritoneal dialysis, and offers other products and services for people with end-stage kidney disease.

*While the company operates in three reportable segments, in October 2010, the company combined its Medication Delivery and Renal businesses into a single global business unit, Medical Products.